[1] Thomas, Brian F., ElSohly, Mahmoud A., “Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents” The Analytical Chemistry of Cannabis, 2016. https://doi.org/10.1016/B978-0-12-804646-3.00002-3
[2] Andre, C. M., Hausman, J. F., & Guerriero, G. (2016). Cannabis sativa: The Plant of the Thousand and One Molecules. Frontiers in plant science, 7, 19. https://doi.org/10.3389/fpls.2016.00019
[3] Rock, E.M., Goodwin, J.M., Limebeer, C.L. et al. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology 215, 505–512 (2011). https://doi.org/10.1007/s00213-010-2157-4
[4] McMaster University. (2020, February 26). Researchers uncover hidden antibiotic potential of cannabis: May serve as a lead for new drug development. ScienceDaily. Retrieved April 23, 2020 from www.sciencedaily.com/releases/2020/02/200226131325.htm
[5] Research Finds How Cannabis Supports Bone Health. (2017, January 4). Retrieved April 30, 2020, from https://www.royalqueenseeds.com/blog-research-finds-how-cannabis-supports-bone-health-n404
[6] Takeda, S., Misawa, K., Yamamoto, I., Wantanabe, K. (2008) Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis. Drug Metabolism and Disposition. 36(9), 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909
[7] Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., … Pertwee, R. G. (2013). Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. British journal of pharmacology, 168(6), 1456–1470. doi:10.1111/bph.12043
[8] DeLong, G.T., Wolf, C.E., Poklis, A., and Lichtman, A.H., 2011. Cannabichromene and tetrahydrocannabinol determination in mouse blood and brain by gas chromatography-mass spectrometry. Journal of Analytical Toxicology, 35 (7), pp. 496–500
[9] Basbaum AI, Bautista DM, Scherrer G, Julius D (October 2009). “Cellular and molecular mechanisms of pain”. Cell. 139 (2): 267–84. doi:10.1016/j.cell.2009.09.028. PMC 2852643. PMID 19837031.
[10] Andersen HH, Elberling J, Arendt-Nielsen L (May 2015). “Human Surrogate Models of Histaminergic and Non-histaminergic Itch”. Acta Dermato-Venereologica. 95 (7): 771–7. doi:10.2340/00015555-2146. PMID 26015312.
[11] https://pubmed.ncbi.nlm.nih.gov/27094344/
[12] Pertwee R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British journal of pharmacology, 153(2), 199–215. https://doi.org/10.1038/sj.bjp.0707442
[13] Deiana, S., Watanabe, A., Yamasaki, Y. et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour. Psychopharmacology 219, 859–873 (2012) doi:10.1007/s00213-011-2415-0
[14] Algae Farm. (2011, July 22). Retrieved June 8, 2020, from https://www.algaefarm.us/cannabinoid-cbd/
Source: https://blog.zilis.com/benefits-of-cannabinoids/
